Scotopic vision Scotopic vision Scotopic vision is the vision of the eye under low-light levels. The term comes from Greek "skotos", meaning "darkness", and "-opia", meaning "a condition of sight". In the human eye, cone cells are nonfunctional in low visible light. Scotopic vision is produced exclusively through rod cells, which are most sensitive to wavelengths of around 498 nm (green–blue) and are insensitive to wavelengths longer than about 640 nm (red). This condition is called the Purkinje effect. Scotopic vision is dominated by retina amacrine cells, specifically AII-amacrine cells. AII-amacrine cells capture rod bipolar cell input and redistribute it to cone
Gene therapy of the human retina and expressing the therapeutic DNA sequence. Since the cells of the retina are non-dividing, AAV continues to persist and provide expression of the therapeutic DNA sequence over a long time period that can last several years. AAV is capable of transducing multiple cell types within the retina. AAV serotype 2, the most well-studied type of AAV, is commonly administered in one of two routes: intravitreal or subretinal. Using the intravitreal route, AAV is injected in the vitreous humor of the eye. Using the subretinal route, AAV is injected underneath the retina, taking advantage of the potential space between the photoreceptors